In this report, we use two murine tumor models in which GCN2 is knocked out to investigate if the anti-tumor effect of PBT is mediated by its effect on GCN2 signaling in stromal cells in the tumor microenvironment. The gene discussed is EIF2AK4; the disease is neoplasm.